Eris Lifesciences

BSE: 540596 | NSE: ERIS
Eris Lifesciences (CIN: L24232GJ2007PLC049867) operates in the Pharmaceuticals industry and has been listed in the stock market since 29th Jun 2017. It currents trades on NSE with symbol ERIS and on BSE with scrip code 540596.
The registered office of the company is 8th floor, Commerce House IV, Beside Shall Petrol Pump, 100 Feet Road, Prahladnagar,Ahmedabad,Gujarat,380015.

The management team of Eris Lifesciences is led by Amit Indubhushan Bakshi who is the Director. Other members of the management team consist of Himanshu Jayantbhai Shah (Designation:Director), Inderjeet Singh Negi (Designation:Director), Mrs. Vijaya Sampath (Designation:Director), Dr. Kirit Nanubhai Shelat (Designation:Director), Milind Talegaonkar (Designation:Company Secretary & Compliance Officer), Sachin Shah (Designation:Chief Financial Officer), .

The price and other financial information of Eris Lifesciences is as below -

BSE 620.05 3.10 (0.50%)

BSE

620.05 3.10 (0.50%)
Volume: 436.00
M. Cap: 8,526.00
P/E: 29.36
Prev. Close: 616.95
Day
52 Wk

NSE

624.50 8.15 (1.32%)
Volume: 13,365.00
M. Cap: 8,526.00
P/E: 29.36
Prev. Close: 616.35
Day
52 Wk

Stock Price Chart

Shareholding Pattern

Category No. of shares Percent(%)
Promoters 7,70,65,474 56.04
General Public 3,29,09,914 23.93
NBFC and Mutual Funds 1,49,26,348 10.85
Foreign Institutions 1,15,74,309 8.42
Financial Institutions 6,89,463 0.50
Others 3,52,114 0.26
Total 13,75,17,622 100

Financial Data

Consolidated
Figures in crore 2018 2017 2016
Net Sales 855.60 749.50 597.02
Operating Profit 348.52 294.25 175.09
Other Income 26.41 25.11 3.37
Interest 10.65 1.10 0.28
Depreciation 25.64 22.76 20.36
Profit Before Tax 312.23 270.39 154.45
Tax 17.25 23.78 19.59
Profit After Tax 294.98 246.61 134.86
Share Capital 13.75 13.75 0.14
Reserves 847.56 553.39 299.11
Net Worth 861.31 567.14 299.25
Loans 376.80 0.65 0.50
Gross Block 819.52 254.43 123.31
Investments 365.37 303.23 190.04
Cash 10.64 2.42 9.69
Debtors 66.64 48.86 25.37
Net Working Capital 130.39 65.44 31.70
Operating Profit Margin (%) 40.73 39.26 29.33
Net Profit Margin (%) 34.48 32.90 22.59
Earning Per Share (Rs) 21.39 17.95 8,453.33
Dividend (%) 0.00 0.00 60,420.00
Dividend Payout 0.00 0.00 83.08
Standalone
Figures in crore 2018 2017 2016
Net Sales 760.60 712.90 605.48
Operating Profit 344.16 296.27 173.76
Other Income 28.22 25.08 3.28
Interest 10.48 0.85 0.28
Depreciation 21.79 21.44 19.55
Profit Before Tax 311.89 273.98 153.93
Tax 18.23 25.84 15.96
Profit After Tax 293.66 248.14 137.97
Share Capital 13.75 13.75 0.14
Reserves 854.43 560.85 305.21
Net Worth 868.18 574.60 305.35
Loans 393.98 21.28 26.08
Gross Block 532.93 113.20 108.20
Investments 545.60 380.61 206.33
Cash 8.81 2.06 8.53
Debtors 60.50 41.30 25.36
Net Working Capital 226.81 123.50 60.31
Operating Profit Margin (%) 45.25 41.56 28.70
Net Profit Margin (%) 38.61 34.81 22.79
Earning Per Share (Rs) 21.36 18.05 8,772.17
Dividend (%) 0.00 0.00 60,420.00
Dividend Payout 0.00 0.00 83.08

Financial Data Graph

The peers of Eris Lifesciences are AUROPHARMA, UNICHEMLAB and MERCK.

* The above data is collected from public sources and we do not guarantee the accuracy of the same.*